Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Jul 2;20(5):e1083–e1120. doi: 10.1016/j.cgh.2021.06.044

Table 4.

Additive interaction between polygenic risk score and body mass index in male and female participants

BMI < 25 kg/m2 BMI ≥ 25 kg/m2 Interaction P-value
All participants (HPFS, NHS and NHS II)
PRSa < 0 Cases/Controls 723/3891 1554/4059
ORb (95% CI) 1.0Ref 2.13 (2.02, 2.24)
PRSa ≥ 0 Cases/Controls 826/3144 1682/3252
ORb (95% CI) 1.42 (1.32, 1.52) 2.90 (2.76, 3.04)
Combined Association
Additive interaction: RERI for (95% Cl); H0c: RERI = 0 0.35 (0.11, 0.60) 4.85×10−3
Additive interaction: SI (95% CI); H0c: SI = 1 1.23 (1.07, 1.38) 8.59×10−3
Multiplicative interaction: IOR (95% CI); H0c: IOR = 1 0.96 (0.82, 1.10) 5.70×10−1
Among females (NHS and NHS II)
PRSa < 0 Cases/Controls 586/3283 1252/3197
ORb (95% CI) 1.0Ref 2.29 (2.17, 2.41)
PRSa ≥ 0 Cases/Controls 681/2630 1369/2545
ORb (95% CI) 1.45 (1.34, 1.56) 3.15 (3.00, 3.30)
Combined Association
Additive interaction: RERI for (95% Cl); H0c: RERI = 0 0.41 (0.12, 0.70) 5.61×10−3
Additive interaction: SI (95% CI); H0c: SI = 1 1.24 (1.08, 1.39) 9.34×10−3
Multiplicative interaction: IOR (95% CI); H0c: IOR = 1 0.95 (0.80, 1.10) 4.97×10−1
Among males (HPFS)
PRSa < 0 Cases/Controls 137/608 302/862
ORb (95% CI) 1.0Ref 1.56 (1.30, 1.82)
PRSa ≥ 0 Cases/Controls 145/514 313/707
ORb (95% CI) 1.25 (1.03, 1.48) 2.01 (1.69, 2.33)
Combined Association
Additive interaction: RERI for (95% Cl); H0c: RERI = 0 0.20 (−0.24, 0.64) 3.77×10−1
Additive interaction: SI (95% CI); H0c: SI = 1 1.24 (0.70, 1.78) 4.30×10−1
Multiplicative interaction: IOR (95% CI); H0c: IOR = 1 1.03 (0.71, 1.35) 8.64×10−1
a

PRS < 0 refers to PRS below the mean. PRS ≥ 0 refers to PRS above or equal to the mean.

b

Odds ratios are unadjusted and conditional on matching factors.

c

H0 = the null hypotheses tests were for RERI = 0; Synergy Index = 1 and interaction odds ratio = 1